Other News
5:03 AM Dec 11, 2018
Black Diamond: Mapping allostery
3:15 PM Dec 07, 2018
Menu
- Home
+ - Publications
+
- Archives
+
- BCIQ
+
- Conferences
+
- eLearning
+
- Follow Us
Latest News
5:02 AM Dec 18, 2018
Erasca launches to target cancer drivers
Oncology company Erasca Inc. (San Diego, Calif.) launched Tuesday with a $42 million series A round and a...
5:00 AM Dec 18, 2018
Entrada raises $59M series A to take intracellular biologic into clinic
Entrada Therapeutics Inc. (Boston, Mass.) emerged from stealth Tuesday after raising $59 million in a...
11:06 PM Dec 17, 2018
China outlines adjuvant drug list
China’s National Health Commission announced plans to create a national adjuvant drug list and...
11:01 PM Dec 17, 2018
Gritstone showcases mass spec-based neoantigen discovery platform
Gritstone Oncology Inc. (NASDAQ:GRTS) unveiled the inner workings of its mass spectrometry-based...
5:01 PM Dec 17, 2018
China gives FibroGen its first approval for roxadustat
After over a decade of development, FibroGen Inc. (NASDAQ:FGEN) said China's National Medical Products...
3:39 PM Dec 17, 2018
Innovent diversifies pipeline with China rights to three Incyte compounds
Innovent Biologics Inc. (HKSE:1801) added three targets and a new modality to its pipeline following a...
3:26 PM Dec 17, 2018
Novo gets option to cardiovascular company Staten
Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) received an option to acquire Staten Biotechnology B.V. (Nijmegen,...
2:38 PM Dec 17, 2018
China approves Junshi’s Tuoyi, first domestic anti-PD-1 mAb
China's National Medical Products Administration (NMPA) conditionally approved on Monday the first...
2:19 PM Dec 17, 2018
Downshifting CARs for better mileage
A study from Michel Sadelain's lab at the Memorial Sloan Kettering Cancer Center suggests that CARs with...
2:09 PM Dec 17, 2018
Management tracks: Vertex’s Graney joins Generation Bio
Tom Graney has left Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) as CFO to take on the same role at non-viral...
1:51 PM Dec 17, 2018
ACA ruling threatens biosimilars provisions
A federal district court ruling Friday that could strike down the entire Affordable Care Act threatens to...
7:34 AM Dec 17, 2018
Versant raises $700M across two funds
Versant Ventures has raised $700 million across two new funds. Versant Venture Capital VII closed at $600...
7:21 AM Dec 17, 2018
FDA picks Flatiron’s Abernethy for No. 2 spot
FDA has hired data scientist and oncologist Amy Abernethy of Flatiron Health Inc. for its No. 2 spot,...
4:02 AM Dec 17, 2018
Proteomics company Seer launches with $36M
Counting nanoparticle pioneer Omid Farokhzad, Robert Langer and Biogen Inc. (NASDAQ:BIIB) vet Philip Ma...
4:06 PM Dec 14, 2018
Shanghai Henlius up for Hong Kong IPO
Biosimilars company Shanghai Henlius Biotech Inc. (Shanghai, China) proposed on Friday to list on the Hong...
4:04 PM Dec 14, 2018
Firdapse re-catalyzes pricing debate
A decision by Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) to charge $375,000 a year for Firdapse...
4:04 PM Dec 14, 2018
J&J shares plummet following asbestos report
Johnson & Johnson (NYSE:JNJ) fell $14.84 (10%) to $133 on Friday, wiping out nearly $40 billion in...
4:02 PM Dec 14, 2018
BIO, PhRMA look to U.S.-Japan trade talks to shape pricing reforms
Forthcoming U.S-Japan trade negotiations could provide industry trade groups BIO and PhRMA a mechanism to...
3:39 PM Dec 14, 2018
FDA approves Celltrion's Herceptin biosimilar
FDA approved a BLA for Herceptin biosimilar Herzuma trastuzumab-pkrb from Celltrion Inc. (KOSDAQ:068270)...
3:37 PM Dec 14, 2018
Amgen pulls out of Advaxis immunotherapy deal
Advaxis Inc. (NASDAQ:ADXS) will continue to enroll patients in a Phase I trial of its ADXS-NEO program...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.